AAAAAA

   
Results: 1-12 |
Results: 12
Cardiovascular effects of tamoxifen in women with and without heart disease: Breast cancer prevention trial
Authors: Reis, SE Costantino, JP Wickerham, DL Tan-Chiu, E Wang, JP Kavanah, M
Citation: Se. Reis et al., Cardiovascular effects of tamoxifen in women with and without heart disease: Breast cancer prevention trial, J NAT CANC, 93(1), 2001, pp. 16-21
Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-23
Authors: Fisher, B Anderson, S Tan-Chiu, E Wolmark, N Wickerham, DL Fisher, ER Dimitrov, NV Atkins, JN Abramson, N Merajver, S Romond, EH Kardinal, CG Shibata, HR Margolese, RG Farrar, WB
Citation: B. Fisher et al., Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-23, J CL ONCOL, 19(4), 2001, pp. 931-942
Ductal carcinoma-in-situ
Authors: Wickerham, DL
Citation: Dl. Wickerham, Ductal carcinoma-in-situ, J CL ONCOL, 19(18), 2001, pp. 98S-100S
Breast cancer chemoprevention: Current status and future directions
Authors: Wickerham, DL Tan-Chiu, E
Citation: Dl. Wickerham et E. Tan-chiu, Breast cancer chemoprevention: Current status and future directions, SEMIN ONCOL, 28(3), 2001, pp. 253-259
Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02
Authors: Wolmark, N Wieand, HS Hyams, DM Colangelo, L Dimitrov, NV Romond, EH Wexler, M Prager, D Cruz, AB Gordon, PH Petrelli, NJ Deutsch, M Mamounas, E Wickerham, DL Fisher, ER Rockette, H Fisher, B
Citation: N. Wolmark et al., Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02, J NAT CANC, 92(5), 2000, pp. 388-396
HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15
Authors: Paik, S Bryant, J Tan-Chiu, E Yothers, G Park, C Wickerham, DL Wolmark, N
Citation: S. Paik et al., HER2 and choice of adjuvant chemotherapy for invasive breast cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-15, J NAT CANC, 92(24), 2000, pp. 1991-1998
Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: Findings from the National Surgical Adjuvant Breast and Bowel Project
Authors: Dignam, JJ Colangelo, L Tian, W Jones, J Smith, L Wickerham, DL Wolmark, N
Citation: Jj. Dignam et al., Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: Findings from the National Surgical Adjuvant Breast and Bowel Project, J NAT CANC, 91(22), 1999, pp. 1933-1940
UFT plus calcium folinate vs 5-FU plus calcium folinate in colon cancer
Authors: Smith, R Wickerham, DL Wieand, HS Colangelo, L Mamounas, EP
Citation: R. Smith et al., UFT plus calcium folinate vs 5-FU plus calcium folinate in colon cancer, ONCOLOGY-NY, 13(7), 1999, pp. 44-47
Health-related quality of life and tamoxifen in breast cancer prevention: A report from the National Surgical Adjuvant Breast and Bowel Project P-1 study
Authors: Day, R Ganz, PA Costantino, JP Cronin, WM Wickerham, DL Fisher, B
Citation: R. Day et al., Health-related quality of life and tamoxifen in breast cancer prevention: A report from the National Surgical Adjuvant Breast and Bowel Project P-1 study, J CL ONCOL, 17(9), 1999, pp. 2659-2669
Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-25
Authors: Fisher, B Anderson, S DeCillis, A Dimitrov, N Atkins, JN Fehrenbacher, L Henry, PH Romond, EH Lanier, KS Davila, E Kardinal, CG Laufman, L Pierce, HI Abramson, N Keller, AM Hamm, JT Wickerham, DL Begovic, M Tan-Chiu, E Tian, W Wolmark, N
Citation: B. Fisher et al., Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-25, J CL ONCOL, 17(11), 1999, pp. 3374-3388
Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: Results from national surgical adjuvant breast and bowel project C-04
Authors: Wolmark, N Rockette, H Mamounas, E Jones, J Wieand, S Wickerham, DL Bear, HD Atkins, JN Dimitrov, NV Glass, AG Fisher, ER Fisher, B
Citation: N. Wolmark et al., Clinical trial to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin, and levamisole in patients with Dukes' B and C carcinoma of the colon: Results from national surgical adjuvant breast and bowel project C-04, J CL ONCOL, 17(11), 1999, pp. 3553-3559
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
Authors: Fisher, B Dignam, J Wolmark, N Wickerham, DL Fisher, ER Mamounas, E Smith, R Begovic, M Dimitrov, NV Margolese, RG Kardinal, CG Kavanah, MT Fehrenbacher, L Oishi, RH
Citation: B. Fisher et al., Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial, LANCET, 353(9169), 1999, pp. 1993-2000
Risultati: 1-12 |